期刊文献+

安慰剂在中药新药临床试验研究中的应用及思考 被引量:7

Application and Consideration of Placebo in Clinical Trial Researches of New Traditional Chinese Medicine
下载PDF
导出
摘要 安慰剂对照临床试验的药效灵敏度和检测灵敏度佳、所需样本量少,可明确反映药物的绝对和真实疗效。在中药新药临床试验研究中应用安慰剂对照可证明中药的真实疗效和安全性,同时积累为国内外主流医药所认可的、可供新药试验选择的阳性中药。科学合理的方案设计和GCP规范管理下的含安慰剂对照的中药临床试验,是中药现代化和国际化的必由之路。安慰剂是随机对照试验中能证明中药临床真实疗效的有效对照之一,在医学伦理能够接受的最大限度内,理应在中药新药临床试验中得到广泛应用。 In placebo-controlled clinical trials, less sample size required, the absolute and real efficacy of a drug can be reflected clearly with good sensitivity of efficacy and detection. Application of placebo-controlled study of traditional Chinese medicine clinical trials can prove the true efficacy and safety of tested traditional Chinese medicine (TCM), and effective positive TCM, recognized by mainstream medicine organizations domestically and internationally, can be found and accumulated in the process. Under scientific and rational protocol design and the GCP management, the placebo-controlled clinical trials of TCM can be the only way leading to TCM modernization and internationalization. Placebo as one of the effective control in randomized controlled trials to prove the real efficacy of TCM should be widely used in new TCM clinical trials, as long as the studies do not violate medical ethics.
出处 《中国现代中药》 CAS 2013年第6期463-466,共4页 Modern Chinese Medicine
关键词 中药 临床试验 安慰剂 新药 Traditional Chinese Medicine(TCM) Clinical trials, Placebo New drug
  • 相关文献

参考文献8

二级参考文献41

  • 1谢红光,周宏灏.安慰剂和安慰剂对照临床试验[J].湖南医学,1994,11(6):362-364. 被引量:1
  • 2卞兆祥,David MOHER,Simon DAGENAIS,李幼平,刘良,吴泰相,缪江霞.提高中草药随机对照试验的质量Ⅱ:对照组设计(英文)[J].中西医结合学报,2006,4(2):130-136. 被引量:24
  • 3Simon R. Are placebo-controlled clinical trials ethical or needed when alternative treatment exists[J]? Ann Intern Med 2000;133:474-475.
  • 4Reynolds T. The ethics of placebo-controlled trials[J]. Ann Intern Med 2000; 133:491-492.
  • 5Vastag B. Helsinki discord? A controversial Declaration[J]. JAMA 2000;284:2983-2985.
  • 6Temple R, Ellenberg SS. Placebo-controlled trials and active-controlled trials in the evaluation of new treatment. Part l: ethical and scientific issues[J]. Ann Intern Med 2000;133:455-463.
  • 7ICH Steering Committee. ICH harmonized tripartite guideline:Choice of control group and related issues in clinical trials. July 2000.
  • 8The European Agency for the Evaluation of Medicinal Products, Preauthorization evaluation of medicines for human use. EMEA/CPMP position statement on the use of placebo in clinical trials with regard to the revised Declaration of Helsinki. EMEA2001 ;17424/01.
  • 9Orentlicher D. Placebo-controlled trials of new drugs: ethical considerations[J]. Diabetes Care 2001 ;24:771-772.
  • 10Simon R. Are placebo-controlled trials ethical or needed when alternative treatment exists[J]? Ann Intern Med 2000; 166:474-475.

共引文献49

同被引文献106

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部